Detalhe da pesquisa
1.
Effectiveness of Upadacitinib for Patients With Acute Severe Ulcerative Colitis: A Multicenter Experience.
Am J Gastroenterol
; 2024 Mar 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38275248
2.
Efficacy and Safety of Dual Targeted Therapy for Partially or Non-responsive Inflammatory Bowel Disease: A Systematic Review of the Literature.
Dig Dis Sci
; 68(6): 2604-2623, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36807832
3.
Tofacitinib for Biologic-Experienced Hospitalized Patients With Acute Severe Ulcerative Colitis: A Retrospective Case-Control Study.
Clin Gastroenterol Hepatol
; 19(10): 2112-2120.e1, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34048936
4.
Correction to: Efficacy and Safety of Dual Targeted Therapy for Partially or Nonresponsive Inflammatory Bowel Disease: A Systematic Review of the Literature.
Dig Dis Sci
; 68(12): 4540, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37891442
5.
Interaction Between the Haptoglobin Genotype and Vitamin E on Cardiovascular Disease in Diabetes.
Curr Diab Rep
; 17(6): 42, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28451949
6.
The Relationship Between Opioid Use and Healthcare Utilization in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
Inflamm Bowel Dis
; 28(12): 1904-1914, 2022 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35230420
7.
Meta-analysis of the association of the haptoglobin genotype with cardiovascular outcomes and the pharmacogenomic interactions with vitamin E supplementation.
Pharmgenomics Pers Med
; 11: 71-82, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29731659
8.
Lentiviral vectors in cancer immunotherapy.
Immunotherapy
; 7(3): 271-84, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25804479